- Home
- AQST vs PNTG Comparison
AQST vs PNTG Comparison
Compare AQST & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | PNTG |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 841.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | PNTG |
|---|---|---|
| Price | $5.93 | $29.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $10.00 | ★ $35.33 |
| AVG Volume (30 Days) | ★ 2.9M | 293.6K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.47 |
| EPS | N/A | ★ 0.75 |
| Revenue | $43,397,000.00 | ★ $847,274,000.00 |
| Revenue This Year | N/A | $36.69 |
| Revenue Next Year | $51.39 | $24.06 |
| P/E Ratio | ★ N/A | $38.74 |
| Revenue Growth | N/A | ★ 29.89 |
| 52 Week Low | $2.12 | $21.18 |
| 52 Week High | $7.55 | $31.97 |
Technical Indicators
Market Signals| Indicator | AQST | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 71.95 |
| Support Level | $5.73 | $27.40 |
| Resistance Level | $6.40 | $26.68 |
| Average True Range (ATR) | 0.35 | 0.92 |
| MACD | 0.05 | 0.33 |
| Stochastic Oscillator | 63.03 | 82.24 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.